Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Altimmune Inc (ALT)

Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 464,408
  • Shares Outstanding, K 70,902
  • Annual Sales, $ 430 K
  • Annual Income, $ -88,450 K
  • 60-Month Beta 0.13
  • Price/Sales 1,246.61
  • Price/Cash Flow N/A
  • Price/Book 3.07
Trade ALT with:

Options Overview Details

View History
  • Implied Volatility 105.81% ( -3.17%)
  • Historical Volatility 97.79%
  • IV Percentile 19%
  • IV Rank 13.42%
  • IV High 356.79% on 10/24/23
  • IV Low 66.90% on 08/23/23
  • Put/Call Vol Ratio 0.27
  • Today's Volume 5,573
  • Volume Avg (30-Day) 9,942
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 104,496
  • Open Int (30-Day) 96,653

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.34
  • Number of Estimates 4
  • High Estimate -0.28
  • Low Estimate -0.37
  • Prior Year -0.32
  • Growth Rate Est. (year over year) -6.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.78 +13.32%
on 06/20/24
8.49 -22.85%
on 06/24/24
+0.64 (+10.83%)
since 06/18/24
3-Month
5.64 +16.13%
on 06/18/24
9.50 -31.05%
on 05/16/24
-0.36 (-5.21%)
since 04/19/24
52-Week
2.09 +213.40%
on 10/23/23
14.84 -55.86%
on 02/28/24
+3.35 (+104.69%)
since 07/19/23

Most Recent Stories

More News
Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics

Both competitors have promising lead programs, and enough cash, too.

LLY : 871.00 (+2.60%)
ALT : 6.55 (unch)
VKTX : 50.40 (+0.60%)
3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics

While their share prices have traveled different paths recently, the similarity between the two companies is striking.

LLY : 871.00 (+2.60%)
MS : 104.50 (-0.30%)
ALT : 6.55 (unch)
VKTX : 50.40 (+0.60%)
If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy

The market for weight loss medicines keeps getting hotter and hotter.

ALT : 6.55 (unch)
NVO : 133.04 (+2.35%)
Altimmune (ALT) Stock Soars 27%: Phase 2 Data on Obesity Drug Ignites Market Optimism

In a remarkable turn of events, Altimmune (NASDAQ: ALT) witnessed a staggering 27% surge in its stock price this morning, fueled by promising clinical data from its Phase 2 trials and heightened investor...

ALT : 6.55 (unch)
Altimmune (ALT) Stock Soars 27%: Phase 2 Data on Obesity Drug Ignites Market Optimism

In a remarkable turn of events, Altimmune (NASDAQ: ALT) witnessed a staggering 27% surge in its stock price this morning, fueled by promising clinical data from its Phase 2 trials and heightened investor...

ALT : 6.55 (unch)
Stocks Set to Open Mixed as Investors Await Key U.S. Inflation Data and Fed Speak

September S&P 500 E-Mini futures (ESU24) are up +0.04%, and September Nasdaq 100 E-Mini futures (NQU24) are down -0.11% this morning as market participants looked ahead to comments from Federal Reserve...

ESU24 : 5,601.50 (+0.13%)
NQU24 : 19,931.75 (+0.16%)
PLTR : 28.76 (+0.41%)
AVGO : 161.89 (+0.85%)
NVDA : 120.80 (-0.24%)
SWBI : 15.67 (+1.16%)
FDS : 431.63 (-2.10%)
NKE : 72.38 (unch)
FDX : 306.50 (-0.04%)
MU : 117.22 (-0.20%)
WBA : 11.36 (unch)
GIS : 65.65 (+0.20%)
Invest in the GLP-1 Drug Market With This New ETF

The market for anti-obesity drugs is massive one, worth potentially $100 billion or more based on some ...

ZLDPF : 124.8900 (-0.88%)
LLY : 871.00 (+2.60%)
NVO : 133.04 (+2.35%)
OZEM : 26.77 (-3.32%)
ALT : 6.55 (unch)
3 Monster Stocks in the Making You Can Buy Right Now

These stocks might not be small for too much longer.

GS : 486.21 (unch)
LLY : 871.00 (+2.60%)
ALT : 6.55 (unch)
AXSM : 82.14 (-1.91%)
VKTX : 50.40 (+0.60%)
Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential

Altimmune has a modest market cap but an incredibly promising GLP-1 drug.

LLY : 871.00 (+2.60%)
ALT : 6.55 (unch)
Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.

Viking Therapeutics has garnered a lot of attention following a successful clinical trial for its obesity care drug. But another development-stage biotech may have a superior candidate.

VKTX : 50.40 (+0.60%)
LLY : 871.00 (+2.60%)
PFE : 29.77 (+0.20%)
ALT : 6.55 (unch)

Business Summary

Altimmune, Inc. is a clinical-stage immunotherapeutics company. It focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease. The company's proprietary platform technologies consist of RespirVec and Densigen. Altimmune Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 8.33
2nd Resistance Point 7.94
1st Resistance Point 7.25
Last Price 6.55
1st Support Level 6.17
2nd Support Level 5.78
3rd Support Level 5.09

See More

52-Week High 14.84
Fibonacci 61.8% 9.97
Fibonacci 50% 8.47
Fibonacci 38.2% 6.96
Last Price 6.55
52-Week Low 2.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar